ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 410 filers reported holding ENCOMPASS HEALTH CORP in Q3 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,164,386 | -37.5% | 95,460 | -30.9% | 0.02% | -42.5% |
| Q4 2022 | $8,261,735 | +17.1% | 138,133 | -11.5% | 0.04% | +8.1% |
| Q3 2022 | $7,058,000 | -39.5% | 156,042 | -25.0% | 0.04% | -35.1% |
| Q2 2022 | $11,660,000 | +791.4% | 208,023 | +1030.6% | 0.06% | +1040.0% |
| Q1 2022 | $1,308,000 | +8.9% | 18,400 | 0.0% | 0.01% | +25.0% |
| Q4 2021 | $1,201,000 | -93.7% | 18,400 | -92.7% | 0.00% | -95.4% |
| Q3 2021 | $18,968,000 | +4.1% | 252,777 | +8.3% | 0.09% | +8.8% |
| Q2 2021 | $18,220,000 | +317.8% | 233,496 | +230.4% | 0.08% | +196.3% |
| Q4 2018 | $4,361,000 | -43.1% | 70,675 | -28.1% | 0.03% | -32.5% |
| Q3 2018 | $7,662,000 | -17.5% | 98,300 | -28.3% | 0.04% | -21.6% |
| Q2 2018 | $9,286,000 | +10.6% | 137,117 | -6.6% | 0.05% | +6.2% |
| Q1 2018 | $8,396,000 | – | 146,857 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 798,931 | $53,656,206 | 4.60% |
| Orchard Capital Management, LLC | 135,466 | $9,097,897 | 3.36% |
| Sivik Global Healthcare LLC | 90,000 | $6,044 | 3.05% |
| BERNZOTT CAPITAL ADVISORS | 128,663 | $8,641,007 | 2.98% |
| REINHART PARTNERS, LLC. | 746,752 | $50,151,893 | 2.60% |
| Integral Health Asset Management, LLC | 250,000 | $16,790,000 | 2.32% |
| Leeward Investments, LLC - MA | 562,001 | $37,743,987 | 1.93% |
| Copeland Capital Management, LLC | 1,277,690 | $85,809,665 | 1.84% |
| Magnetar Financial LLC | 1,060,733 | $71,238,828 | 1.82% |
| Advantage Alpha Capital Partners LP | 122,252 | $8,210,444 | 1.72% |